FDA Head Califf Says He Won't Need To Fight To Stay
This article was originally published in The Rose Sheet
Executive Summary
FDA's new commissioner may be asked to leave the agency when a new president arrives, but he believes it may not come to that.
You may also be interested in...
Califf Nomination May Show Confidence In His Bipartisan Appeal
After seven months as deputy commissioner for medical products and tobacco, Robert Califf tapped to be FDA Commissioner.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
US FDA Hopes Food, Inspection Office Reorg Bolsters Innovative Clinical Trial Adoption
Ensuring inspectors understand the innovative trial designs in use before an inspection will be important to increasing industry confidence in their use, CDER Director Patrizia Cavazzoni said.